Literature DB >> 7670726

P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.

I von Kügelgen1, D Stoffel, K Starke.   

Abstract

1. We looked for P2-purinoceptors modulating noradrenaline release in rat heart atria. Segments of the atria were preincubated with [3H]-noradrenaline and then superfused with medium containing desipramine (1 microM) and yohimbine (1 microM) and stimulated electrically, by 30 pulses/1 Hz unless stated otherwise. 2. The adenosine A1-receptor agonist, N6-cyclopentyl-adenosine (CPA; EC50 9.7 nM) and the nucleotides, ATP (EC50 6.6 microM) and adenosine-5'-O-(3-thiotriphosphate) (ATP gamma S; EC50 4.8 microM), decreased the evoked overflow of tritium. The adenosine A2a-agonist, 2-p-(2-carbonylethyl)-phenethylamino-5'-N-ethylcarboxamido-a denosine (CGS-21680; 0.03-0.3 microM) and the P2x-purinoceptor agonist beta, gamma-methylene-L-ATP (30 microM) caused no change. 3. The concentration-response curve of CPA was shifted to the right by the adenosine A1-receptor antagonist, 8-cyclopentyl-1,3-dipropyl-xanthine (DPCPX; 3 nM; apparent pKB value 9.7) but hardly affected by the P2-purinoceptor antagonist, cibacron blue 3GA (30 microM). In contrast, the concentration-response curves of ATP and ATP gamma S were shifted to the right by DPCPX (3 nM; apparent pKB values 9.3 and 9.4, respectively) as well as by cibacron blue 3GA (30 microM; apparent pKB values 5.0 and 5.1, respectively). Combined administration of DPCPX and cibacron blue 3GA caused a much greater shift of the concentration-response curve of ATP than either antagonist alone. The concentration-response curve of ATP was not changed by indomethacin, atropine or the 5'-nucleotidase blocker alpha, beta-methylene-ADP. 4. Cibacron blue 3GA (30 microM) increased the evoked overflow of tritium by about 70%. The increase was smaller when the slices were stimulated by 9 pulses/O00 Hz instead of 30 pulses/I Hz.5. The results indicate that the postganglionic sympathetic axons in rat atria possess P2-purinoceptors in addition to the known adenosine Al-receptor. Both mediate inhibition of noradrenaline release. Some adenine nucleotides such as ATP and ATP gamma S act at both receptors. The presynaptic P2-purinoceptor seems to be activated by an endogenous ligand, presumably ATP, under the condition of these experiments. This is the first evidence for presynaptic P2-purinoceptors at cardiac postganglionic sympathetic axons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7670726      PMCID: PMC1908323          DOI: 10.1111/j.1476-5381.1995.tb15870.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  48 in total

1.  Axon terminal P2-purinoceptors in feedback control of sympathetic transmitter release.

Authors:  I von Kügelgen; K Kurz; K Starke
Journal:  Neuroscience       Date:  1993-09       Impact factor: 3.590

2.  ATP and endogenous agonists inhibit evoked [3H]-noradrenaline release in rat iris via A1 and P2y-like purinoceptors.

Authors:  H Fuder; U Muth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

Review 3.  Presynaptic modulation of the release of the co-transmitters noradrenaline and ATP.

Authors:  I von Kügelgen; K Kurz; R Bültmann; B Driessen; K Starke
Journal:  Fundam Clin Pharmacol       Date:  1994       Impact factor: 2.748

4.  Inhibitory and facilitatory effects of purines on transmitter release from sympathetic nerves.

Authors:  L D Todorov; R A Bjur; D P Westfall
Journal:  J Pharmacol Exp Ther       Date:  1994-02       Impact factor: 4.030

5.  ATP modulates the efferent function of capsaicin-sensitive neurones in guinea-pig isolated atria.

Authors:  A Rubino; S Amerini; F Ledda; L Mantelli
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

6.  Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptors.

Authors:  K Kurz; I von Kügelgen; K Starke
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

7.  Purinoceptor-mediated modulation by endogenous and exogenous agonists of stimulation-evoked [3H]noradrenaline release on rat iris.

Authors:  H Fuder; A Brink; M Meincke; U Tauber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

8.  Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens.

Authors:  U Grimm; H Fuder; U Moser; H G Bümert; E Mutschler; G Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

9.  Stable adenine nucleotides inhibit [3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors.

Authors:  I von Kügelgen; L Späth; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

10.  P2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens.

Authors:  I von Kügelgen; K Kurz; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

View more
  12 in total

1.  P2Y purinoceptor activation mobilizes intracellular Ca2+ and induces a membrane current in rat intracardiac neurones.

Authors:  D M Liu; C Katnik; M Stafford; D J Adams
Journal:  J Physiol       Date:  2000-07-15       Impact factor: 5.182

Review 2.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

3.  Local regulation of [(3)H]-noradrenaline release from the isolated guinea-pig right atrium by P(2X)-receptors located on axon terminals.

Authors:  B Sperlágh; F Erdélyi; G Szabó; E S Vizi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  Release inhibitory receptors activation favours the A2A-adenosine receptor-mediated facilitation of noradrenaline release in isolated rat tail artery.

Authors:  Paula Fresco; Carmen Diniz; Glória Queiroz; Jorge Gonçalves
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

5.  The effect of nucleotides and adenosine on stimulus-evoked glutamate release from rat brain cortical slices.

Authors:  G C Bennett; M R Boarder
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

6.  Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y- and facilitatory A2A-purinoceptors.

Authors:  J Gonçalves; G Queiroz
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

7.  P2Y receptor regulation of cultured rat cerebral cortical cells: calcium responses and mRNA expression in neurons and glia.

Authors:  Gillian C Bennett; Anthony P D W Ford; Jacqueline A M Smith; Caroline J Emmett; Tania E Webb; Michael R Boarder
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

8.  Vasoconstrictor responses to the P2x-purinoceptor agonist beta, gamma-methylene-L-ATP in human cutaneous and renal blood vessels.

Authors:  I von Kügelgen; B Krumme; U Schaible; P J Schollmeyer; L C Rump
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

9.  Purinergic receptors in the splanchnic circulation.

Authors:  Manuela Morato; Teresa Sousa; António Albino-Teixeira
Journal:  Purinergic Signal       Date:  2008-04-29       Impact factor: 3.765

10.  P2 receptor-mediated modulation of neurotransmitter release-an update.

Authors:  Beáta Sperlágh; Attila Heinrich; Cecilia Csölle
Journal:  Purinergic Signal       Date:  2007-10-09       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.